Róbert Babeľa is a specialist in the field of health technology assessment, which he has been working on for more than a decade. He is a graduate of three universities including the Open University Business School, London, UK and the University of Sheffield, Sheffield, UK. He is the author and co-author of more than 180 publications at home and abroad, and has gained practical skills during his more than 20 years in various positions in the healthcare sector, where he continues to work. Prof. PhDr. Róbert Babeľa, PhD., MBA, MSc (HTA), FISAC is a member of several editorial boards of international journals and professional companies. He currently focuses on scientific projects related to the quantification of the actual total costs of sel…

CEO of M-Change s.r.o. and as a senior project manager at HealthHub - Centre for Innovative Healthcare. She specializes in the preparation and coordination of national and international projects funded from various sources and the comprehensive implementation of these projects. Her focus is primarily on the areas of digitalization, applied research, clinical trials, and investment projects. Currently, she leads a dynamically developing company with an international reach. She participates in the preparation of strategic documents for VAIA in the working group of the Healthy Society domain. She is involved in the transformation of healthcare, processes for improving the quality and economy of healthcare, and activities in patient safety.…

Pavol Lepey has more than 26 years of experience working in healthcare. Worked on healthcare transformation and innovation at Roche. For several years he successfully led the representation of Medtronic in Slovakia and the Czech Republic, worked for Abbott Laboratories and focused on the implementation of new diagnostic and therapeutic tools in clinical and laboratory practice.

Mgr. Ing. Roman Mužik, PhD. MSc. He is the manager of the department of strategy and innovation in health care at the health insurance company Dôvera. He studied physiotherapy, public policy, human resource management and management in healthcare. He has 15 years of experience in healthcare in various positions. The subject of his interest is mainly health policy, telemedicine and managed health care programs for chronically ill patients.

Ingel KM Demedts, MD, PhD Working as a Pulmonologist/Thoracic Oncologist in AZ Delta Hospital in Roeselare (Belgium), with a focus on the diagnosis and treatment of patients with lung cancer. PhD in Medical Sciences at the Ghent University with a  PhD  thesis entitled: “Role of Dendritic Cells and Matrix Metalloproteinase-12 in the  pathogenesis of Chronic Obstructive Pulmonary Disease”.   Special interest in clinical trials, Value Based Healthcare and the use of artificial intelligence in medicine. Guest Professor at the Department of Pulmonary Diseases, Ghent University Hospital. Member of the National College for Oncology in Belgium. Awarded in 2019 with the International Value Based Healthcare Award for cost-effectiv…

Marcel Mikolášik is the director of the strategy department of the General Health Insurance Company (VšZP), where the Value for Money department also operates. It focuses, among other things, on building the ability to better assess value for money in the context of a health insurance company. Within this, one of the goals of VšZP is to constantly streamline the resources spent on health care and medicines. Marcel Mikolášik has almost 20 years of experience in financial services and consulting, including projects, products and risk management.